Valeant Pharmaceuticals International (VRX) Announces 2013 Annual Meeting Results
5/22/2013 6:10:57 AM
More...
|
Valeant Pharmaceuticals International (VRX) to Present at 34th Annual Goldman, Sachs & Co. Global Healthcare Conference
5/21/2013 6:32:42 AM
More...
|
Valeant Pharmaceuticals International (VRX) Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors
5/16/2013 7:12:39 AM
More...
|
Valeant Pharmaceuticals International (VRX) to Webcast 2013 Annual Meeting of Shareholders
5/14/2013 6:55:06 AM
More...
|
Valeant Pharmaceuticals International (VRX) Announces Additional Information Regarding Continuance Proposal
5/13/2013 9:51:52 AM
More...
|
Valeant Pharmaceuticals International (VRX) Provides Efinconazole Update
5/3/2013 9:35:13 AM
More...
|
Valeant Pharmaceuticals International (VRX) Reports 2013 First Quarter Financial Results
5/2/2013 7:01:58 AM
More...
|
Actavis Buys Antibiotic Vaginal Gel From Valeant Pharmaceuticals International (VRX) for $55 Million
5/1/2013 7:30:00 AM
More...
|
Valeant Pharmaceuticals International (VRX) in Talks to Buy Actavis for Over $13 Billion Put on Hold
4/29/2013 8:13:30 AM
More...
|
Valeant Pharmaceuticals International (VRX) Completes Tender Offer for Obagi Medical Products, Inc. (OMPI)
4/25/2013 11:21:05 AM
More...
|
|